We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RMTI market cap is 41.31M. The company's latest EPS is USD -0.2962 and P/E is -4.93.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 18.69M | 19.31M | 19.67M | 18.08M | 23.77M |
| Operating Income | -3.71M | -1.97M | -1.43M | -2.96M | -1.74M |
| Net Income | -4.19M | -2.36M | -1.75M | -3.31M | -1.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 61.3M | 62.2M | 61.93M | 72.81M | 83.61M |
| Operating Income | -34.53M | -28.42M | -30.34M | -16.78M | -6.67M |
| Net Income | -34.13M | -30.89M | -32.67M | -18.68M | -8.44M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 54.19M | 46.64M | 40.47M | 38.04M | 52.61M |
| Total Liabilities | 38.05M | 32.53M | 27.93M | 28.51M | 31.09M |
| Total Equity | 16.14M | 14.11M | 12.54M | 9.53M | 21.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.32M | 77.75M | 48.57M | 46.64M | 52.17M |
| Total Liabilities | 24M | 43.58M | 46.04M | 32.53M | 30.88M |
| Total Equity | 20.32M | 34.17M | 2.54M | 14.11M | 21.29M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.82M | -17.41M | -3.88M | -5.62M | -9.37M |
| Investing | -5.61M | -2.4M | 5.3M | 5.24M | -5.05M |
| Financing | 22.13M | 16.63M | -631k | -761k | 12.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.26M | -29.64M | -33.53M | -17.41M | -9.41M |
| Investing | -4.75M | 3.21M | 311k | -2.4M | -3.05M |
| Financing | 21.09M | 63.32M | -2.18M | 16.63M | 11.34M |
| Market Cap | 41.31M |
| Price to Earnings Ratio | -4.93 |
| Price to Sales Ratio | 0.5 |
| Price to Cash Ratio | 4.63 |
| Price to Book Ratio | 1.95 |
| Dividend Yield | - |
| Shares Outstanding | 28.49M |
| Average Volume (1 week) | 132.69k |
| Average Volume (1 Month) | 228.81k |
| 52 Week Change | -30.95% |
| 52 Week High | 6.24 |
| 52 Week Low | 1.16 |
| Spread (Intraday) | 0.18 (10.98%) |
| Company Name | Rockwell Medical Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.rockwellmed.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
